These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28091345)

  • 1. Propofol as a Risk Factor for ICU-Acquired Weakness in Septic Patients with Acute Respiratory Failure.
    Abdelmalik PA; Rakocevic G
    Can J Neurol Sci; 2017 May; 44(3):295-303. PubMed ID: 28091345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical review: intensive care unit acquired weakness.
    Hermans G; Van den Berghe G
    Crit Care; 2015 Aug; 19(1):274. PubMed ID: 26242743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Critical illness polyneuropathy and myopathy as neurological complications of sepsis].
    Kollmar R
    Nervenarzt; 2016 Mar; 87(3):236-45. PubMed ID: 26842898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperlactacidemia as a risk factor for intensive care unit-acquired weakness in critically ill adult patients.
    Yang T; Li Z; Jiang L; Xi X
    Muscle Nerve; 2021 Jul; 64(1):77-82. PubMed ID: 33831220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive Care Unit- Acquired Weakness and Hospital Functional Mobility Outcomes Following Invasive Mechanical Ventilation in Patients with COVID-19: A Single-Centre Prospective Cohort Study.
    Núñez-Seisdedos MN; Lázaro-Navas I; López-González L; López-Aguilera L
    J Intensive Care Med; 2022 Aug; 37(8):1005-1014. PubMed ID: 35578542
    [No Abstract]   [Full Text] [Related]  

  • 6. Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome.
    Bercker S; Weber-Carstens S; Deja M; Grimm C; Wolf S; Behse F; Busch T; Falke KJ; Kaisers U
    Crit Care Med; 2005 Apr; 33(4):711-5. PubMed ID: 15818093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive care unit-acquired weakness and the COVID-19 pandemic: A clinical review.
    Qin ES; Hough CL; Andrews J; Bunnell AE
    PM R; 2022 Feb; 14(2):227-238. PubMed ID: 35014183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective study.
    Frithiof R; Rostami E; Kumlien E; Virhammar J; Fällmar D; Hultström M; Lipcsey M; Ashton N; Blennow K; Zetterberg H; Punga AR
    Clin Neurophysiol; 2021 Jul; 132(7):1733-1740. PubMed ID: 33875374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intensive care unit-acquired weakness: development of polyneuropathy and myopathy in critically ill patients].
    Takei T
    Brain Nerve; 2014 Feb; 66(2):161-70. PubMed ID: 24523314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for intensive care unit-acquired weakness: A systematic review and meta-analysis.
    Yang T; Li Z; Jiang L; Wang Y; Xi X
    Acta Neurol Scand; 2018 Aug; 138(2):104-114. PubMed ID: 29845614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, Time Course and Influence on Quality of Life of Intensive Care Unit-Acquired Weakness Symptoms in Long-Term Intensive Care Survivors.
    Meyer-Frießem CH; Malewicz NM; Rath S; Ebel M; Kaisler M; Tegenthoff M; Schildhauer TA; Pogatzki-Zahn EM; Maier C; Zahn PK
    J Intensive Care Med; 2021 Nov; 36(11):1313-1322. PubMed ID: 32799703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive care unit-acquired weakness.
    Horn J; Hermans G
    Handb Clin Neurol; 2017; 141():531-543. PubMed ID: 28190434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ICU-Acquired Weakness: A Rehabilitation Perspective of Diagnosis, Treatment, and Functional Management.
    Zorowitz RD
    Chest; 2016 Oct; 150(4):966-971. PubMed ID: 27312737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Care and treatments related to intensive care unit-acquired muscle weakness: A cohort study.
    Raurell-Torredà M; Arias-Rivera S; Martí JD; Frade-Mera MJ; Zaragoza-García I; Gallart E; Velasco-Sanz TR; San José-Arribas A; Blazquez-Martínez E;
    Aust Crit Care; 2021 Sep; 34(5):435-445. PubMed ID: 33663950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive Care Unit-Acquired Weakness.
    Kramer CL
    Neurol Clin; 2017 Nov; 35(4):723-736. PubMed ID: 28962810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An official American Thoracic Society Clinical Practice guideline: the diagnosis of intensive care unit-acquired weakness in adults.
    Fan E; Cheek F; Chlan L; Gosselink R; Hart N; Herridge MS; Hopkins RO; Hough CL; Kress JP; Latronico N; Moss M; Needham DM; Rich MM; Stevens RD; Wilson KC; Winkelman C; Zochodne DW; Ali NA; ;
    Am J Respir Crit Care Med; 2014 Dec; 190(12):1437-46. PubMed ID: 25496103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive care unit-acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock.
    Schefold JC; Bierbrauer J; Weber-Carstens S
    J Cachexia Sarcopenia Muscle; 2010 Dec; 1(2):147-157. PubMed ID: 21475702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteral nutrition management in critically ill adult patients and its relationship with intensive care unit-acquired muscle weakness: A national cohort study.
    Zaragoza-García I; Arias-Rivera S; Frade-Mera MJ; Martí JD; Gallart E; San José-Arribas A; Velasco-Sanz TR; Blazquez-Martínez E; Raurell-Torredà M
    PLoS One; 2023; 18(6):e0286598. PubMed ID: 37285356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fitness and mobility training in patients with Intensive Care Unit-acquired muscle weakness (FITonICU): study protocol for a randomised controlled trial.
    Mehrholz J; Thomas S; Burridge JH; Schmidt A; Scheffler B; Schellin R; Rückriem S; Meißner D; Mehrholz K; Sauter W; Bodechtel U; Elsner B
    Trials; 2016 Nov; 17(1):559. PubMed ID: 27881152
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.